Working… Menu

Phase I/Ib Multiple Ascending Dose Study in China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03523390
Recruitment Status : Completed
First Posted : May 14, 2018
Last Update Posted : May 13, 2021
Information provided by (Responsible Party):
Merck KGaA, Darmstadt, Germany

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 29, 2019
Actual Study Completion Date : February 8, 2021